These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Integrase inhibitor gains FDA approval. Traynor K Am J Health Syst Pharm; 2007 Nov; 64(22):2310. PubMed ID: 17989435 [No Abstract] [Full Text] [Related]
7. Dolutegravir (Tivicay) for HIV. Med Lett Drugs Ther; 2013 Sep; 55(1426):77-9. PubMed ID: 24081387 [No Abstract] [Full Text] [Related]
8. HIV integrase inhibitors--out of the pipeline and into the clinic. Havlir DV N Engl J Med; 2008 Jul; 359(4):416-8. PubMed ID: 18650518 [No Abstract] [Full Text] [Related]
9. Agenerase approved by FDA. Gaylord G Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061 [No Abstract] [Full Text] [Related]
10. Integrase inhibitors in the treatment of HIV-1 infection. Powderly WG J Antimicrob Chemother; 2010 Dec; 65(12):2485-8. PubMed ID: 20852268 [TBL] [Abstract][Full Text] [Related]
11. High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors. Charpentier C; Laureillard D; Piketty C; Tisserand P; Batisse D; Karmochkine M; Si-Mohamed A; Weiss L AIDS; 2010 Mar; 24(6):867-73. PubMed ID: 20160635 [TBL] [Abstract][Full Text] [Related]
13. Integrase inhibitors for the treatment of HIV infection. Pace P; Rowley M Curr Opin Drug Discov Devel; 2008 Jul; 11(4):471-9. PubMed ID: 18600564 [TBL] [Abstract][Full Text] [Related]
14. [Integrase inhibition--a new mode of action in HIV therapy]. van Lunzen J; Degen O MMW Fortschr Med; 2008 Apr; 150 Spec No 1():64-7. PubMed ID: 19031567 [No Abstract] [Full Text] [Related]